Forte Biosciences, Inc. (FBRX)
NASDAQ·Healthcare·Biotechnology
$17.69
+3.12%
Mkt Cap $264.80M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$65.00
Range $65.00 – $65.00
Implied Upside
+267.5%
Consensus $65.00 vs current $17.69
NASDAQ·Healthcare·Biotechnology
$17.69
+3.12%
Mkt Cap $264.80M
No recent rating data.
Price Target (1 analysts)
$65.00
Range $65.00 – $65.00
+267.5%
Consensus $65.00 vs current $17.69